Skip to main content

Table 3 Prevalence of liver impairment

From: Anti-hepatitis C antibody carriage and risk of liver impairment in rural-Cameroon: adapting the control of hepatocellular carcinoma for resource-limited settings

TRANSAMINASES

N = 306

Normal

n(%)

Abnormal

n(%)

ALT

183(59.80)

123 (40.20)

AST

162 (52.29)

144 (47.06)

AST + ALT

138 (45.09)

93 (30.39)